UNION therapeutics announces full-year results for 2024

Hellerup, Denmark, February 12, 2025, – UNION therapeutics A/S (“UNION”), a privately held, clinical stage, pharmaceutical development company focused on immunology, announces full-year results for the period January 1 to […]